Paruresis in women
Almost everything published about paruresis is addressed to men. This page is the correction, and it is short — because little has been found out about women, not because there is little to say. Where it says nothing was found, that is our own search of the literature rather than a source's finding.
Nobody has counted, and almost nobody has looked
No study we found measures how often paruresis is diagnosed, in either sex. What can be shown is who was in the research. One survey reached 63 people through a membership organisation, and four of them were women. [Vythilingum 2002] Understanding paruresis carries the by-sex figures the site has.
One paper did ask whether the condition looks different in women. Nearly all of its participants were men:
most of participants were male (87.7%; N=57). Although gender differences in the clinical manifestations of the disorder appear limited, the variable mostly connected to the severity of paruresis is the presence of a further diagnosis of generalized social phobia.
Appear limited, on about eight women. It is the only sign anyone has that this presents much the same in women as in men, and it is a thin one. The same paper ends on "limited knowledge among mental health professionals" [Prunas 2013]. That is about everybody, not about women.
A difference nobody could find is not a difference nobody has. A sample this small can hide one.
On the one paper that asked whether this looks different in women and in men
A cubicle is not privacy
A women's toilet is a room of cubicles, so a door can look like the answer. The women who have been asked do not describe privacy that way.
The largest survey of how women use public toilets took free-text answers from 5397 of them [Hartigan 2020], and its authors say barriers to using a toilet at work or in public "have been minimally studied" [Hartigan 2020]. This is what they found privacy meant:
Privacy can mean using a restroom alone so that others cannot see, hear, or smell what you are doing.
A cubicle door closes one of those three. That survey is about public toilets rather than paruresis, and most of the women in it do not have this condition. The paruresis half is that urinary difficulty rises "as the level of privacy decreases" [Knowles 2016]. Privacy is a dial, not a switch, so a cubicle can raise it without ending anything.
The researchers behind a UK survey of paruresis ask employers for something else. They recommend that organisations "consider building single gender, single occupancy toilets and locating toilets in quiet non-communal areas" [Hutchings 2024], which is their position rather than a tested result.
None of this shows that the cubicle is why women are missing from the research. Nobody has tested it, and the one report on how the condition presents by sex found the differences limited. [Prunas 2013]
Catheterisation is not the same procedure
Your options sets out what clean intermittent self-catheterisation is for. Paruresis is not on the European nurses' guideline's list of what it is prescribed for. That list starts here:
acute or chronic urinary retention due to nonneurogenic or neurogenic conditions
We found nothing published that tests it as a treatment for this. What follows is only what differs for women, because a woman who goes looking will mostly find the male case.
The guideline's own sequence runs together part of the way, and then divides into a female version and a male one. [EAUN 2025] Neither is the default, and the reason it divides is anatomy:
Strictures are more common in men because the male urethra is longer than the female’s and the female urethra is straighter than the male’s.
Infection runs the other way. A urinary tract infection is "the most common complication" of catheterising [EAUN 2025], and the guideline's table of what raises that risk lists being female among the factors:
Table 10. Factors increasing the risk of infection in IC | Risk factor | LE [...] Female [48, 69] | 1b [...]
That is a table rather than a sentence: the bars divide the cells, "[...]" stands for the rows left out, and LE is the level of evidence. The guideline defines 1b as "Evidence obtained from at least one randomised trial" [EAUN 2024]. That grades the kind of study the finding came out of; nobody randomised anyone's sex.
None of this is a reason to work it out alone: "IC should be taught by an appropriately experienced nurse" [EAUN 2025]. How to tell a real catheter from a dangerous one covers the equipment side.
Where this leaves you
The research has not looked at you. That is a fact about the research rather than about you, and it is not a reason to wait.
Two things a clinician can test for, and a web page cannot. One is dysfunctional voiding. The flow starts and stops because the muscles around the urethra tighten on their own while you go, "in neurologically normal women" [ICS glossary]. A journal for GPs says it "has been noted to share similar symptoms with paruresis". What tells them apart is the place: paruresis "is isolated to unfamiliar or busy public restrooms" [Kuoch 2019]. The other is retention itself. In women it "is an uncommon and poorly understood condition" of its own. In one form, Fowler's syndrome, the sphincter relaxes poorly, and a recording of its electrical activity shows "a distinct abnormal pattern" [Osman 2014]. If you cannot pass urine anywhere, not only in public, that is a reason to be examined. It is not a reason to assume it is this.
The person who can say what applies to your body is a clinician who can examine you, and the Doctor Brief is a page written to be handed across a desk.
No clinician has checked this one. Every claim above is on the sources page, with the words behind it.
This page was last checked on .
Hand this to a doctor